Healthcare Analytics, Population Health Management, Healthcare Big Data

Precision Medicine

Consumers Curious About AI, Genetic Testing for Precision Medicine

September 26, 2018 - Healthcare consumers are cautious but optimistic that emerging strategies like artificial intelligence and advanced genetic testing can lead to better care for cancer, according to a new survey from McKesson and Ipsos. The poll of more than 2000 individuals found that close to two-thirds (60 percent) of respondents are open to the idea of using genetic testing to identify their risk of...


More Articles

Amazon, APIs to Support Cloud Informatics Platform for Life Sciences

by Jennifer Bresnick

Amazon Web Services (AWS), Accenture, and Merck have announced a collaboration to create a cloud-based informatics research platform to support advances in the life sciences. The project will accelerate drug development by improving...

$21M Grant to “All of Us” Orgs Will Support Precision Medicine Research

by Jessica Kent

The HHS Health Resources and Services Administration (HRSA) has awarded $21 million to 46 community health centers to support their participation in NIH’s All of Us precision medicine research program. The grant will allow community...

Machine Learning, Genomics Predict Risk of Aortic Aneurysm

by Jennifer Bresnick

The combination of machine learning tools and genomic data can help predict the risk of abdominal aortic aneurysm (AAA), one of the most frequently fatal heart conditions - and one that is most often diagnosed only after a patient’s...

10 High-Value Use Cases for Predictive Analytics in Healthcare

by Jennifer Bresnick

As healthcare organizations develop more sophisticated big data analytics capabilities, they are beginning to move from basic descriptive analytics towards the realm of predictive insights. Predictive analytics may only be the second of...

MIT Machine Learning Tool Reduces Cancer Treatment Toxicity

by Jessica Kent

MIT researchers have developed a machine learning algorithm that could proactively adjust toxic chemotherapy and radiotherapy dosing for patients with glioblastoma to minimize the toxic effects of the treatments. Glioblastoma, an...

Precision Medicine Researchers Identify New Alzheimer’s Genes

by Jessica Kent

Researchers from Boston University School of Medicine, in collaboration with scientists from the Alzheimer’s Disease Sequencing Project (ADSP), have discovered new genes that could contribute to the onset of Alzheimer’s...

Georgetown Offers Brain Cancer Data for Precision Medicine Research

by Jessica Kent

Georgetown Lombardi Comprehensive Cancer Center will now make its collection of brain cancer data freely available to precision medicine researchers worldwide. The dataset, called the REpository for Molecular BRAin Neoplasia DaTa...

How Artificial Intelligence is Changing Radiology, Pathology

by Jessica Kent

Artificial intelligence and machine learning tools have the potential to analyze large datasets and extract meaningful insights to enhance patient outcomes, an ability that is proving helpful in radiology and pathology. Images obtained by...

How to Bring Precision Medicine into Routine Clinical Care

by Jessica Kent

Precision medicine has taken the healthcare industry by storm in recent years, offering the promise of more individualized treatments, improved patient outcomes, and a deeper understanding of genetic conditions and rare...

VA, IBM Watson Extend AI, Genomics Partnership for Cancer Care

by Jessica Kent

The Department of Veteran Affairs (VA) and IBM Watson Health have announced an extension of their partnership to bring artificial intelligence and genomic analytics to cancer care. The VA’s precision oncology program primarily...

UPMC, UPitt Launch Genome Sequencing Center for Medical Research

by Jessica Kent

The University of Pittsburgh Medical Center (UPMC) and the University of Pittsburgh have announced the creation of the UPMC Genome Center, an advanced genome sequencing facility that will enhance clinical diagnostics and support precision...

AARP Invests $60M in Dementia, Alzheimer’s Disease Research

by Jessica Kent

The AARP’s  Brain Health Fund will invest $60 million in the Dementia Discovery Fund (DDF) to accelerate the development of innovative treatments for dementia and Alzheimer’s disease, which have profound impacts on...

NCI Studies Link Dozens of Genetic Variants to Cancer

by Jessica Kent

The discovery of genetic variants that are associated with cancer development could assist providers with identifying high-risk patients and crafting precision medicine therapies for oncology, according to new research funded by the...

Clinical Decision Support from Dana-Farber Powers Cancer Care

by Jessica Kent

Experts at Dana-Farber Cancer Institute are partnering with Royal Philips to provide improved clinical decision support for cancer care. The incredibly complex nature of cancer, coupled with its many available treatment options, has long...

FDA: Drug Development Transparency Key for Precision Medicine

by Jessica Kent

New guidance from the FDA urges drug development stakeholders to be transparent with their data as a way to maintain high quality and foster patient-centered precision medicine.   Innovative, personalized treatments are being...

WVU Genetic Test to Improve Lung Cancer Treatment

by Jessica Kent

Researchers at the West Virginia University (WVU) Cancer Institute are developing a genetic test that will improve treatment for patients with lung cancer and help physicians determine which patients will benefit from chemotherapy and...

NIH Precision Medicine Clinical Trial Releases New Findings

by Jessica Kent

The National Cancer Institute’s Molecular Analysis for Therapy Choice (NCI-MATCH) trial, the largest precision medicine trial of its kind, has released results from several sub-studies that could bring targeted treatments to patients...

Broader Availability of Genetic Testing a Boon for Precision Care

by Jennifer Bresnick

Precision medicine is quickly moving out of the realm of science fiction and into the everyday routines of oncologists, neurologists, and other providers treating patients who may have had little hope just a few short years ago. While the...

NIH Recommends Precision Medicine Approach to Treat Alzheimer’s

by Jessica Kent

Precision medicine, big data analytics, and stakeholder collaboration could improve treatment and prevention of Alzheimer’s disease and related dementias, according to recommendations from the National Institutes of Health...

X

Join 25,000 of your peers

Register for free to get access to all our articles, webcasts, white papers and exclusive interviews.

Our privacy policy

no, thanks

Continue to site...